All In Biotech

Drug Trial Radar · NCT07668414

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Efficacy and Safety of Zenagamtide s.c. Once-weekly Compared to Semaglutide s.c. Once-weekly in Participants With Obesity (AMAZE 7)

Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 650 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

650

Planned (sponsor's estimate)

Start

Sep 22, 2026

Primary completion

Oct 10, 2028

Study completion Oct 10, 2028

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Jun 25, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treatment with semaglutide.

Conditions

  • Overweight
  • Obesity

Interventions

  • ZenagamtideDrug

    Zenagamtide will be administered subcutaneously using pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • SemaglutideDrug

    Semaglutide will be administered subcutaneously using pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to semaglutide)Drug

    Placebo matched to semaglutide will be administered subcutaneously using pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to zenagamtide)Drug

    Placebo matched to zenagamtide will be administered subcutaneously using pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From week 0 to week 84

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • First Valley Medical Group

    Lancaster, California · Recruiting

  • Desert Oasis Healthcare

    Palm Springs, California · Recruiting

  • Western University of Health Sciences

    Pomona, California · Recruiting

  • Artemis Insitute for Clin Res

    San Diego, California · Recruiting

  • Med Home Development Grp

    Washington D.C., District of Columbia · Recruiting

  • Encore Medical Research LLC

    Hollywood, Florida · Recruiting

  • NextPhase Research

    Hollywood, Florida · Recruiting

  • Jacksonville Ctr Clin Res

    Jacksonville, Florida · Not yet recruiting

  • PharmaDev Clinical Research Institute LLC

    Miami, Florida · Recruiting

  • South Broward Research LLC

    Miramar, Florida · Recruiting

  • Essence MD Research

    Naples, Florida · Not yet recruiting

  • Florida Inst For Clin Res LLC

    Orlando, Florida · Recruiting

  • Oviedo Medical Research, LLC

    Oviedo, Florida · Recruiting

  • Palm Beach Research Center

    West Palm Beach, Florida · Recruiting

  • Encore Medical Research of Weston

    Weston, Florida · Recruiting

  • Conquest Research

    Atlanta, Georgia · Recruiting

  • Eastside Bariatric and Gen Surg

    Snellville, Georgia · Recruiting

  • Chicago Research Center, Inc

    Chicago, Illinois · Not yet recruiting

  • Endeavor Health

    Skokie, Illinois · Recruiting

  • Midwest Inst For Clin Res

    Indianapolis, Indiana · Recruiting

  • Southern Clin Research

    Zachary, Louisiana · Not yet recruiting

  • Amicis Centers of Clinical Research

    St Louis, Missouri · Recruiting

  • Ichor Research

    Syracuse, New York · Recruiting

  • Southgate Medical Group, LLP

    West Seneca, New York · Recruiting

  • PharmQuest Life Sciences LLC

    Greensboro, North Carolina · Not yet recruiting

  • Piedmont Healthcare/Research

    Statesville, North Carolina · Recruiting

  • Lillestol Research LLC

    Fargo, North Dakota · Recruiting

  • Geisinger Clinic

    Danville, Pennsylvania · Recruiting

  • Medical University Of South Carolina

    Charleston, South Carolina · Recruiting

  • Hillcrest Clinical Research

    Simpsonville, South Carolina · Recruiting

  • Spartanburg Medical Research

    Spartanburg, South Carolina · Recruiting

  • Amarillo Med Spec LLP

    Amarillo, Texas · Recruiting

  • Texas Diabetes & Endocrinology

    Austin, Texas · Recruiting

  • Pinnacle Clinical Research

    Brownsville, Texas · Recruiting

  • Osvaldo A. Brusco MD

    Corpus Christi, Texas · Recruiting

  • UT Southwestern Med Center

    Dallas, Texas · Not yet recruiting

  • Epic Medical Research

    DeSoto, Texas · Not yet recruiting

  • Houston Research Institute

    Houston, Texas · Not yet recruiting

  • The Endocrine Center

    Houston, Texas · Not yet recruiting

  • Sleep Therapy Research Center

    San Antonio, Texas · Not yet recruiting

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.